Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2235 participants.

Also called NCT04931771

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,235 participants (enrolled count) (from the registry)
Sponsor
  • ECRI bv Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04931771
Other papers using this trial's data
  • Angiography-Based Physiology to Guide Coronary Revascularization The New England journal of medicine, 2026-07-02 DOI, PubMed 41910382

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Germany, Ireland, Italy, Netherlands, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04931771. Randomized; no masking; primary purpose treatment. Start 2021-11-09 (actual); primary completion 2025-12-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization
Acronym
FAST III
Intervention (Device)
vFFR guided revascularization
Intervention (Device)
FFR guided revascularization
Lead sponsor
ECRI bv (class: industry)
Collaborator
Siemens Healthineers (class: industry)
Collaborator
Pie Medical Imaging (class: not stated)

Record details

Record id
cardio:ct-nct04931771
Content hash
45f15a047a08e6394efe33a5421bb37155cac3ba5688eed07ce4b9e69cf98906